Brief: Ackermans & Van Haaren Invests In Astrivax

Ackermans & Van Haaren NV

25/08/2022 06:09

Aug 25 (Reuters) - Ackermans & Van Haaren NV  ACKB.BR :
    * ACKERMANS & VAN HAAREN INVESTS IN ASTRIVAX
    * IS ANNOUNCING ITS INVESTMENT IN ASTRIVAX, A SPIN-OFF FROM
THE KU
LEUVEN REGA INSTITUTE
    * COMPANY IS CLOSING 30 MILLION EUROS CAPITAL ROUND
    * OVER TIME AVH WILL GAIN A 7.7% SHAREHOLDING OF ASTRIVAX
    * ASTRIVAX WILL USE THE SEED CAPITAL TO BRING THEIR FIRST
THERMOSTABLE YELLOW FEVER VACCINE TO THE CLINICAL DEVELOPMENT
STAGE AND TO FURTHER DEVELOP THEIR PIPELINE VACCINE CANDIDATES
    * HANNE CALLEWAERT, PHD, WILL LEAD THE COMPANY AS CEO

Further company coverage:  ACKB.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))